Successful treatment of Diamond-Blackfan anemia with metoclopramide

American Journal of Hematology

Volumn 78, Issue 4, 2005, Pages 295-298

  Akiyama, Masaharu ^a   Yanagisawa, Takaaki ^a   Yuza, Yuki ^a   Yokoi, Kentaro ^a   Ariga, Masamichi ^a   Fujisawa, Kohji ^a   Hoshi, Yasutaka ^a,b   Eto, Yoshikatsu ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JIKEI UNIVERSITY HOSPITAL   (Japan)

Author keywords

Diamond Blackfan anemia; Metoclopramide; Prolactin

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN A; METOCLOPRAMIDE; TACROLIMUS;

ADULT; ARTICLE; BLACKFAN DIAMOND ANEMIA; BONE MARROW; CASE REPORT; CELL DIFFERENTIATION; ERYTHROCYTE TRANSFUSION; ERYTHROPOIESIS; GRANULOCYTE; HUMAN; INFECTION; IRON OVERLOAD; MALE; MEGAKARYOCYTE; PRIORITY JOURNAL; REFRACTORY ANEMIA; RETICULOCYTE COUNT;

ADULT; ANEMIA, DIAMOND-BLACKFAN; DOPAMINE ANTAGONISTS; HEMOGLOBINS; HUMANS; MALE; METOCLOPRAMIDE; PROLACTIN; RETICULOCYTE COUNT; TREATMENT OUTCOME;

EID: 16344362309     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.20278     Document Type: Article

References (17)

1. Diamond LK, Blackfan KD. Hypoplasia anemia. Am J Dis Child 1938;56:464-467.
2. Costa LD, Willing TN, Fixler J, Mohandas N, Tchernia G. Diamond-Blackfan anemia. Curr Opin Pediatr 2001;13:10-15.
3. Ohga S, Mugishima H, Ohara A, et al. Diamond-Blackfan anemia in Japan: clinical outcomes of prednisolone therapy and hematopoietic stem cell transplantation. Int J Hematol 2004;79:22-30.
4. El-Beshlawy A, Ibrahim IY, Rizk S, Eid K. Study of 22 Egyptian patients with Diamond-Blackfan anemia, corticosteroids, and cyclosporin therapy results. Pediatrics 2002;110:e44.
5. Splain J, Berman BW. Cyclosporin A treatment for Diamond-Blackfan anemia. Am J Hematol 1992;39:208-211.
6. Gillio AP, Faulkner LB, Alter BP. Treatment of Diamond-Blackfan anemia with recombinant human interleukin-3. Blood 1993;82:744-751.
7. Bernini JC, Carrillo JM, Buchanan GR. High dose intravenous methylprednisolone therapy for patients with Diamond-Blackfan anemia refractory to conventional doses of prednisone. J Pediatr 1995;127:654-659.
8. Dianzani I, Garelli E, Ramenghi U. Diamond-Blackfan anemia: an overview. Pediatr Drugs 2000;2:345-355.
9. Tseng SB, Lin SF, Chang CS, et al. Successful treatment of acquired pure red cell aplasia (PRCA) by allogenic peripheral blood stem cell transplantation. Am J Hematol 2003;74:273-275.
10. Ball SE, McGuckin CP, Jenkins G, Gordon-Smith EC. Diamond-Blackfan anemia in the U.K.: analysis of 80 cases from a 20-year birth cohort. Br J Hematol 1996;94:645-653.
11. Janov AJ, Leong T, Nathan DG. Diamond-Blackfan anemia: natural history and sequelae of treatment. Medicine 1996;75:77-87.
12. Abkowitz JL, Schaison G, Boulad F, et al. Response of Diamond-Blackfan anemia to metoclopramide: evidence for a role for prolactin in erythropoiesis. Blood 2002;100:2687-2691.
13. Yu-Lee LY. Prolactin modulation of immune and inflammatory responses. Recent Prog Horm Res 2002;57:435-455.
14. Judd SJ, Lazarus L, Smythe G. Prolactin secretion by metoclopramide in man. J Clin Endocrinol Metab 1976;43:313-317.
15. Aapro MS, Thuerlimann B, Sessa C, et al. A randomized double-blind trial to compare the clinical efficacy of granisetron with metoclopramide, both combined with dexamethasone in the prophylaxis of chemotherapy-induced delayed emesis. Ann Oncol 2003;14:291-297.
16. Jepson JH, McGarry EE. Effects of the anabolic protein hormone prolactin on human erythropoiesis. J Clin Pharmacol 1974;14:296-300.
17. Bellone G, Astarita P, Artusio E, et al. Bone marrow stroma-derived prolactin is involved in basal and platelet-activating factor-stimulated in vitro erythropoiesis. Blood 1997;90:21-27.